NTNX Form 4: Director Robert Lavender Receives 843 RSUs
Rhea-AI Filing Summary
Robert G. Lavender, a director of Nutanix, Inc. (NTNX), was granted restricted stock units (RSUs) that cover 843 shares of Class A common stock. The RSUs were issued on 09/17/2025 at no cash price and remain unvested. They vest in full on the earlier of (i) the day before the next annual meeting of shareholders after the grant date or (ii) the one-year anniversary of the grant, provided the reporting person continues service through the applicable vesting date. The Form 4 was filed on 09/19/2025 by an attorney-in-fact.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director received time-based RSUs aligning interests with shareholders; vesting is service-based within one year or before the next annual meeting.
The grant of 843 RSUs to a director is a routine equity-based compensation mechanism to align a director's incentives with long-term shareholder value. The award vests on a short-term schedule (earlier of one year or prior to the next annual meeting) and is contingent on continued service, which is common for non-employee directors. The Form 4 discloses no exercised options, sales, or cash proceeds; the instrument is a contingent right to one share per RSU. Impact on outstanding share count or dilution is not provided in this filing.
TL;DR: This is a standard, non-cash director equity award with short-term vesting; materiality appears limited based on the disclosed quantity.
The filing shows an award of 843 RSUs at $0 price, which will convert into Class A common shares upon vesting. Short-form vesting schedules like this suggest alignment for the coming year rather than long-term retention. The filing does not disclose aggregate holdings of the director or the percentage impact on total shares outstanding, so assessing materiality relative to company size is not possible from this document alone.